http://www.zacks.com/stock/news/425808/biomarins-vimizim-wins-nod-in-china-for-rare-genetic-malady?cid=CS-ZC-FT-425808
Jun 06, 2019 - BioMarin's (BMRN) Vimizim gains an NMPA nod in China for addressing patients suffering Morquio A syndrome, an ultra-rare genetic condition.
zc:8777108214768214018
0
http://www.zacks.com/stock/news/526215/zynerba-releases-data-on-epilepsy-candidate-stock-down?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-526215
Sep 19, 2019 - Zynerba (ZYNE) announces positive top-line results from the BELIEVE 1 study evaluating the efficacy and safety of Zygel in a heterogeneous group of rare and ultra-rare epilepsies.
zc:3953479812269660558
0
http://www.zacks.com/stock/news/532018/the-zacks-analyst-blog-highlights-dr-reddys-wns-and-azure-power?cid=CS-ZC-FT-press_releases-532018
Sep 23, 2019 - The Zacks Analyst Blog Highlights: Dr. Reddy's, WNS and Azure Power
zc:3856272750323769472
0
http://www.zacks.com/stock/news/543304/mylan-myl-to-pay-%2430m-to-settle-sec-charges-for-epipen?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-543304
Sep 30, 2019 - Mylan (MYL) sinks after the SEC charges it for misclassification of EpiPen.
zc:-9136703935706512660
0
http://www.zacks.com/stock/news/614102/new-strong-sell-stocks-for-november-11th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_#5_rank_stocks-614102
Nov 11, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
zc:4389617323508910609
0
http://www.zacks.com/stock/news/617737/new-strong-sell-stocks-for-november-13th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_#5_rank_stocks-617737
Nov 13, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
zc:6665849794215270234
0
http://www.zacks.com/stock/news/621253/new-strong-sell-stocks-for-november-15th?cid=CS-ZC-FT-tale_of_the_tape|new_zacks_#5_rank_stocks-621253
Nov 15, 2019 - Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
zc:-806378981812021166
0
http://www.zacks.com/stock/news/277080/teva-reintroduces-generic-depo-provera-injection-in-us?cid=CS-ZC-FT-277080
Sep 27, 2017 - Teva (TEVA) announced the reintroduction of the generic equivalent to Depo-Prover Contraceptive Injection 150 mg/mL in the United States.
zc:-9089973710765206232
0
http://www.zacks.com/stock/news/282370/vivus-vvus-q3-loss-narrows-qsymia-falters-shares-down?cid=CS-ZC-FT-282370
Nov 09, 2017 - VIVUS (VVUS) reported third-quarter results wherein it reported narrower-than- expected loss. However, Qsymia sales fell from the year-ago period.
zc:8838643073073590322
0
http://www.zacks.com/stock/news/290129/dr-reddys-rdy-q3-earnings-fall-revenues-improve-y-y?cid=CS-ZC-FT-290129
Jan 25, 2018 - Dr. Reddy's (RDY) earnings per American Depositary Share were down 27.3% in third-quarter fiscal 2018 from the year-ago quarter while the top line beat the prior-year figure.
zc:-7424064638699899882
0